Oncocross, JW Pharma: AI-Driven Anticancer, Regenerative Drug Development
27 May 2024 //
BUSINESSWIRE
Oncocross expands collab with JW for AI-based oncology drug discovery in Korea
27 May 2024 //
BIOSPECTRUM ASIA
Oncocross completes Phase I sarcopenia trial in Australia
11 May 2023 //
CLINICAL TRIALS ARENA
Oncocross Completes Phase I Global Clinical Trial of OC514, for Sarcopenia
10 May 2023 //
BUSINESSWIRE